Similar articles

• A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases.

  Dequeker J, Decock T, Walravens M, Van de Putte I. Dequeker J, et al. J Rheumatol. 1978 Winter;5(4):452-9. J Rheumatol. 1978. PMID: 739494
• Coexistence of HLA-B27 ankylosing spondylitis and DR4 seropositive nodular rheumatoid arthritis in patient with membranous nephropathy.

  Lemmer JP, Irby WR. Lemmer JP, et al. J Rheumatol. 1981 Jul-Aug;8(4):661-4. J Rheumatol. 1981. PMID: 6975378
• [Seronegative spondylo-arthropathies and HLA-B27].

  Kaludi M. Kaludi M. Union Med Can. 1984 Jun;113(6):455-9, 521. Union Med Can. 1984. PMID: 6333098 French. No abstract available.
• [Histocompatability antigens in rheumatic diseases].

  Tannenbaum H. Tannenbaum H. Union Med Can. 1976 Apr;105(4):581-4. Union Med Can. 1976. PMID: 793131 Review. French. No abstract available.
• [Reactive arthritis: the status of the problem and the outlook].

  Agababova ER. Agababova ER. Revmatologiia (Mosk). 1985 Jan-Mar;(1):3-6. Revmatologiia (Mosk). 1985. PMID: 3890080 Review. Russian. No abstract available.